Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00110149
Status:
TERMINATED
Last Update Posted:
2017-11-21
First Post:
2005-05-03
Brief Title:
Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkins Lymphoma
Sponsor:
Beth Israel Deaconess Medical Center
Organization:
Beth Israel Deaconess Medical Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| stage IV small lymphocytic lymphoma | View |
| contiguous stage II grade 1 follicular lymphoma | View |
| noncontiguous stage II grade 1 follicular lymphoma | View |
| stage I grade 1 follicular lymphoma | View |
| stage III grade 1 follicular lymphoma | View |
| stage IV grade 1 follicular lymphoma | View |
| contiguous stage II grade 2 follicular lymphoma | View |
| noncontiguous stage II grade 2 follicular lymphoma | View |
| stage I grade 2 follicular lymphoma | View |
| stage III grade 2 follicular lymphoma | View |
| stage IV grade 2 follicular lymphoma | View |
| contiguous stage II marginal zone lymphoma | View |
| noncontiguous stage II marginal zone lymphoma | View |
| splenic marginal zone lymphoma | View |
| stage I marginal zone lymphoma | View |
| stage III marginal zone lymphoma | View |
| stage IV marginal zone lymphoma | View |
| extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| nodal marginal zone B-cell lymphoma | View |
| contiguous stage II small lymphocytic lymphoma | View |
| noncontiguous stage II small lymphocytic lymphoma | View |
| stage I small lymphocytic lymphoma | View |
| stage III small lymphocytic lymphoma | View |